Most patients with renal medullary carcinoma (RMC) have advanced disease at presentation and rarely respond to radiation or chemotherapy. We describe two adolescents with metastatic disease who had significant responses to cisplatin or carboplatin in combination with gemcitabine and paclitaxel.
- Renal medullary carcinoma
- Sickle cell trait
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health